Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BIGBIO Herlev ApS
APS
Active
Advertising protection
CVR 35515755
Herlev Hovedgade 31, 2730
Herlev
Motion picture projection activities
·
NACE 5914
Est. 2013 · 12 years old
45 employees
Monitor
Share
Denmark
/
Companies
/
Motion picture projection activities
/
BIGBIO Herlev ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
20M
15M
10M
5M
0M
2021: 10M
10M
2021
2022: 16M (+60% vs 2021)
16M
+60%
2022
2023: 11M (-31% vs 2022)
11M
-31%
2023
2024: 10M (-9% vs 2023)
10M
-9%
2024
2025: 9M (-10% vs 2024)
9M
-10%
2025
EBITDA
DKK millions
11M
8M
6M
3M
0M
2021: 4M
4M
2021
2022: 9M (+125% vs 2021)
9M
+125%
2022
2023: 3M (-67% vs 2022)
3M
-67%
2023
2024: 3M (0% vs 2023)
3M
0%
2024
2025: 2M (-33% vs 2024)
2M
-33%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
8.607
9.804
10.892
15.764
10.184
Staff expenses
-6.243
-6.982
-7.712
-6.661
-6.403
EBITDA
2.364
2.821
3.180
9.103
3.781
Depreciation & amort.
-298
-458
-1.231
-1.357
-1.035
EBIT
2.065
2.364
1.949
7.746
2.745
Net financials
239
340
472
140
74
Profit before tax
2.304
2.703
2.421
7.887
2.819
Tax
508
597
540
1.736
621
Net profit
1.796
2.107
1.881
6.150
2.198
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
17.721
15.969
17.665
24.476
16.574
Equity
8.641
6.845
11.238
15.357
9.206
Long-term debt
0
0
0
0
0
Short-term debt
9.079
9.124
6.426
9.119
7.368
Total debt
9.079
9.124
6.426
9.119
7.368
Financial ratios
5-year trend
EBITDA margin (of gross profit)
27,5 %
This company
2021
2025
Equity ratio
48,8 %
This company
38,2 %
Market median
This company
Market median
28% above market
2021
2025
Return on equity
20,8 %
This company
18,4 %
Market median
This company
Market median
13% above market
2021
2025
Net profit margin (of gross profit)
20,9 %
This company
2021
2025
Asset turnover (of gross profit)
0,49×
This company
2021
2025
Debt / equity
1,05×
This company
0,62×
Market median
This company
Market median
69% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on BIGBIO Herlev ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
